LP-98

N/A

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NameLP-98
Drug Alias NameLP-98
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Lipopeptide antibiotics
Mechanisms of ActionHIV fusion inhibitorsTransmembrane glycoprotein gp41 inhibitors
TargetsTransmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanxi Kangbao Biological Product Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInstitute Of Pathogenic Biology Chinese Academy Of Medical SciencesShanxi Kangbao Biological Product Co Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A